These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31554435)

  • 1. Prevalence of
    Lopes LR; Futema M; Akhtar MM; Lorenzini M; Pittman A; Syrris P; Elliott PM
    Amyloid; 2019 Dec; 26(4):243-247. PubMed ID: 31554435
    [No Abstract]   [Full Text] [Related]  

  • 2. Transthyretin amyloidosis: a phenocopy of hypertrophic cardiomyopathy.
    Vermeer AMC; Janssen A; Boorsma PC; Mannens MMAM; Wilde AAM; Christiaans I
    Amyloid; 2017 Jun; 24(2):87-91. PubMed ID: 28475415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
    Porcari A; Razvi Y; Masi A; Patel R; Ioannou A; Rauf MU; Hutt DF; Rowczenio D; Gilbertson J; Martinez-Naharro A; Venneri L; Whelan C; Lachmann H; Wechalekar A; Quarta CC; Merlo M; Sinagra G; Hawkins PN; Fontana M; Gillmore JD
    Eur J Heart Fail; 2023 Apr; 25(4):515-524. PubMed ID: 36644836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosis.
    Prokaeva T; Klimtchuk ES; Feschenko P; Spencer B; Cui H; Burks EJ; Aslebagh R; Muneeruddin K; Shaffer SA; Varghese E; Berk JL; Connors LH
    Amyloid; 2023 Jun; 30(2):141-152. PubMed ID: 36286264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare c.302C>T
    Žebrauskienė D; Sadauskienė E; Masiulienė R; Aidietienė S; Šiaudinienė A; Pečeliūnas V; Žukauskaitė G; Žurauskas E; Valevičienė N; Barysienė J; Preikšaitienė E
    Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399526
    [No Abstract]   [Full Text] [Related]  

  • 6. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
    Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A
    Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid heart disease mimicking hypertrophic cardiomyopathy.
    Mörner S; Hellman U; Suhr OB; Kazzam E; Waldenström A
    J Intern Med; 2005 Sep; 258(3):225-30. PubMed ID: 16115295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: Neurological and cardiological features.
    Gentile L; Di Bella G; Minutoli F; Cucinotta F; Obici L; Mussinelli R; Arimatea I; Russo M; Toscano A; Vita G; Mazzeo A
    J Peripher Nerv Syst; 2020 Sep; 25(3):273-278. PubMed ID: 32395865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
    Damrauer SM; Chaudhary K; Cho JH; Liang LW; Argulian E; Chan L; Dobbyn A; Guerraty MA; Judy R; Kay J; Kember RL; Levin MG; Saha A; Van Vleck T; Verma SS; Weaver J; Abul-Husn NS; Baras A; Chirinos JA; Drachman B; Kenny EE; Loos RJF; Narula J; Overton J; Reid J; Ritchie M; Sirugo G; Nadkarni G; Rader DJ; Do R
    JAMA; 2019 Dec; 322(22):2191-2202. PubMed ID: 31821430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three patients of transthyretin amyloidosis in a Japanese family with amyloidogenic transthyretin Thr49Ser (p.Thr69Ser) variant.
    Ikura H; Kitakata H; Endo J; Moriyama H; Sano M; Tsujikawa H; Sawano M; Masuda T; Ohki T; Ueda M; Kosaki K; Fukuda K
    Eur J Med Genet; 2022 Mar; 65(3):104451. PubMed ID: 35149236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cardiac involvement, extracardiac manifestations and outcomes between homozygote and heterozygote transthyretin p.Val142Ile (V122I) variant in patients with hereditary transthyretin amyloidosis: a cohort study.
    Albenque G; Bézard M; Kharoubi M; Odouard S; Lunati A; Poullot E; Zaroui A; Teiger E; Hittinger L; Audard V; El Karoui K; Funalot B; Fanen P; Damy T; Oghina S
    Amyloid; 2023 Dec; 30(4):407-415. PubMed ID: 37377439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study.
    Trachtenberg BH; Jimenez J; Morris AA; Kransdorf E; Owens A; Fishbein DP; Jordan E; Kinnamon DD; Mead JO; Huggins GS; Hershberger RE;
    Genet Med; 2022 Jul; 24(7):1495-1502. PubMed ID: 35438637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Screening for Pathogenic Transthyretin Variants Finds Evidence of Underdiagnosed Amyloid Cardiomyopathy From Health Records.
    Carry BJ; Young K; Fielden S; Kelly MA; Sturm AC; Avila JD; Martin CL; Kirchner HL; Fornwalt BK; Haggerty CM;
    JACC CardioOncol; 2021 Oct; 3(4):550-561. PubMed ID: 34746851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
    Razvi Y; Ioannou A; Patel RK; Chacko L; Karia N; Riefolo M; Porcari A; Rauf MU; Starr N; Ganesananthan S; Blakeney I; Kaza N; Filisetti S; Bolhuis RE; Rowczenio D; Gilbertson J; Hutt D; Mahmood S; Lachmann HJ; Wechalekar AD; Kotecha T; Knight DS; Coghlan JG; Petrie A; Whelan CJ; Venneri L; Martinez-Naharro A; Hawkins P; Fontana M; Gillmore JD
    Eur J Heart Fail; 2024 Feb; 26(2):383-393. PubMed ID: 37953725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Prevalence of Clinically Apparent Cardiac Amyloidosis Among Carriers of Transthyretin V122I Variant in a Large Electronic Medical Record.
    Agbor-Etang BB; Okafor HE; Farber-Eger EH; Wells QS
    Am J Med; 2021 Feb; 134(2):e98-e100. PubMed ID: 32866461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Transthyretin Mutation G47V Associated with Hereditary Cardiac Amyloidosis.
    He X; Wang M; Sun J; Yu Z; Hu X; Liu Y; Lin X
    Cardiology; 2024; 149(4):383-395. PubMed ID: 38437799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical exome sequencing unravels the diverse spectrum of genetic heterogeneity and genotype-phenotype correlations in hypertrophic cardiomyopathy.
    Harikrishnan S; Koshy L; Ganapathi S; Jeemon P; Ramya Das NK; Urulangodi M; Madhuma M; Vysakh Y; Subran A; Lakshmikanth LR
    Int J Cardiol; 2024 Sep; 411():132273. PubMed ID: 38880420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.
    Parker MM; Damrauer SM; Tcheandjieu C; Erbe D; Aldinc E; Hawkins PN; Gillmore JD; Hull LE; Lynch JA; Joseph J; Ticau S; Flynn-Carroll AO; Deaton AM; Ward LD; Assimes TL; Tsao PS; Chang KM; Rader DJ; Fitzgerald K; Vaishnaw AK; Hinkle G; Nioi P
    Sci Rep; 2021 Jun; 11(1):11645. PubMed ID: 34079032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I
    Hendren NS; De Lemos JA; Berry JD; Kozlitina J; Saelices L; Ji AX; Shao Z; Liu CF; Garg S; Farr MA; Drazner MH; Tang WHW; Grodin JL
    Amyloid; 2024 Jun; 31(2):124-131. PubMed ID: 38445629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.